Hans Loibner
- Molecular Biology top 5%
- Oncology top 2%
- Cardiology and Cardiovascular Medicine top 2%
- Immunology top 5%
- Infectious Diseases top 2%
- Co-authors
- Manfred SchusterJosef PenningerErich ZbiralGavin Y. OuditZamaneh KassiriJiuchang ZhongFung L. ChowDanny Guo
- Topics
- Immunotherapy and Immune Responses (29 papers)Neuroblastoma Research and Treatments (23 papers)Monoclonal and Polyclonal Antibodies Research (22 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Hans Loibner
100 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.3k
- Oncology 1.2k
- Cardiology and Cardiovascular Medicine 907
- Immunology 677
- Infectious Diseases 555
Countries citing papers authored by Hans Loibner
This map shows the geographic impact of Hans Loibner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Loibner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Loibner more than expected).
Fields of papers citing papers by Hans Loibner
This network shows the impact of papers produced by Hans Loibner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Loibner. The network helps show where Hans Loibner may publish in the future.
Co-authorship network of co-authors of Hans Loibner
This figure shows the co-authorship network connecting the top 25 collaborators of Hans Loibner. A scholar is included among the top collaborators of Hans Loibner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Loibner. Hans Loibner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 4 | |
| 4 | 18 | |
| 5 | 54 | |
| 6 | 14 | |
| 7 | 52 | |
| 8 | 44 | |
| 9 | 50 | |
| 10 | 90 | |
| 11 | 89 | |
| 12 | 90 | |
| 13 | 249 | |
| 14 | 2 | |
| 15 | Humoral immune response to linear EpCAM-peptides induced by the mimotope cancer vaccine IGN101: Assessment by two independent methods | 1 |
| 16 | 6 | |
| 17 | 1 | |
| 18 | 61 | |
| 19 | 18 | |
| 20 | 23 |
About Hans Loibner
Hans Loibner is a scholar working on Immunology, Neurology and Oncology, having authored 106 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (29 papers), Neuroblastoma Research and Treatments (23 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). The work is most often cited by research in Oncology (1.2k citations), Cardiology and Cardiovascular Medicine (907 citations) and Immunology (677 citations). Hans Loibner has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Manfred Schuster, Josef Penninger, Erich Zbiral, Gavin Y. Oudit, Zamaneh Kassiri, Jiuchang Zhong, Fung L. Chow, Danny Guo, Ratnadeep Basu and Evelyne Janzek. Their work appears in journals such as Circulation, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.